BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 17065200)

  • 21. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
    Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
    Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
    Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
    J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
    Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer chemoprevention by silibinin: bench to bedside.
    Singh RP; Agarwal R
    Mol Carcinog; 2006 Jun; 45(6):436-42. PubMed ID: 16637061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis.
    Alexia C; Bras M; Fallot G; Vadrot N; Daniel F; Lasfer M; Tamouza H; Groyer A
    Ann N Y Acad Sci; 2006 Dec; 1090():1-17. PubMed ID: 17384242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
    J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.
    Ma Y; Cheng Q; Ren Z; Xu L; Zhao Y; Sun J; Hu S; Xiao W
    Cancer Lett; 2012 Apr; 317(2):150-6. PubMed ID: 22115966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
    Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation.
    Lecosnier S; Cordier C; Simon P; François JC; Saison-Behmoaras TE
    FASEB J; 2011 Jul; 25(7):2201-10. PubMed ID: 21402719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
    Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
    Ligęza J; Ligęza J; Klein A
    Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
    Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone.
    Weigent DA; Arnold RE
    Cell Immunol; 2005 Mar; 234(1):54-66. PubMed ID: 15964559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
    Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
    Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.